Diagnostic News and Research

RSS

MDD with subthreshold hypomania ‘should be merged with bipolar II’

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates and other characteristics compared with those with major depression alone, research shows.

10 Oct 2012

FDA clears Surefire's Angiographic Catheter line

Surefire Medical, Inc. announced today that the company has received 510(k) FDA clearance to market its line of Surefire Angiographic Catheters. Surefire Medical will launch these products in the United States later this year.

10 Oct 2012

Salivary-biomarker approach can identify individuals at future risk of PTSD, depression

Each year, more than a million Americans are at-risk of developing serious mental health problems after experiencing a terrifying event or serious physical injury. Once manifested, these psychiatric illnesses, such as post-traumatic stress disorder and depression, can be extremely crippling and difficult to treat and are a leading cause of disability in civilian, military and minority populations.

10 Oct 2012

CT technique could improve COPD classification

The parametric response map technique can be used in chronic obstructive pulmonary disease to distinguish between disease subtypes, say US researchers.

9 Oct 2012

Isolated fetal echogenic bowel ‘may be benign’

Results of a Dutch study show that the majority of fetuses with fetal echogenic bowel carry a good prognosis.

9 Oct 2012

PENTAX Medical to release new EPK-i7000 video processor and i10 series endoscopes

PENTAX Medical, a healthcare industry leader in endoscopic imaging, will release the next generation High Definition (HD+) EPK-i7000 video processor and i10 series endoscopes during the United European Gastroenterology week from October 20-24, 2012 in Amsterdam, The Netherlands.

From PENTAX Medical Company 9 Oct 2012

Eddy Scurlock Stroke Center receives DNV's Comprehensive Stroke Center certification

The Methodist Neurological Institute's Eddy Scurlock Stroke Center, the largest stroke unit in Houston's Texas Medical Center, is the first hospital in the United States to receive a comprehensive stroke center certification by DNV Healthcare Inc.

8 Oct 2012

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it has entered into a collaboration and commercialization agreement with H. Lundbeck A/S.

8 Oct 2012

NovaSom launches full-service testing program for pre-operative diagnosis of OSA

NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announces the launch of AccuSom Safe Recovery.

8 Oct 2012

Standard red blood cell transfusion as good as fresh RBCs for premature infants

Among premature, very low-birth-weight infants requiring a transfusion, use of fresh red blood cells (RBCs) compared with standard RBC transfusion practice did not improve clinical outcomes that included rates of complications or death, according to a study in the October 10 issue of JAMA.

8 Oct 2012

St. Jude Medical launches 3-D navigation system that reduces need for live fluoroscopy

St. Jude Medical, Inc., a global medical device company, today announced the launch of its MediGuide Technology, the first and only three-dimensional (3-D) navigation system intended for the evaluation of vascular and cardiac anatomy on a recorded fluoroscopic image instead of live fluoroscopy (a series of X-ray images).

8 Oct 2012

Rainbow, Amarantus report joint venture agreement for NuroPro Parkinson's diagnostic platform

Rainbow Coral Corp. biotech subsidiary Rainbow BioSciences and Amarantus Biosciences have moved into the final stages of the terms for a deal. The pending joint venture agreement will see the two entities working together to move the Amarantus NuroPro Parkinson's diagnostic platform towards commercialization.

8 Oct 2012

Patient navigation services can reduce dangerous delays in identification of breast cancer

Today researchers from The George Washington University published a study showing that breast cancer patients can reduce potentially dangerous delays in the identification of breast cancer with the assistance of patient navigation services.

8 Oct 2012

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.

8 Oct 2012

GW professor to develop blood test for early detection of breast cancer

Today, patients with precancerous lesions, or early-stage breast cancer are usually diagnosed after a mammography screening. This method of detection can lead to false-positives and overtreatment, since mammography cannot determine whether pre-cancerous cells will actually turn into breast cancer. This may all change after Sidney Fu, M.D., professor of medicine at the George Washington School of Medicine and Health Sciences (SMHS), completes his study of early breast cancer detection using novel small RNA (microRNA or miRNA) biomarkers.

5 Oct 2012

Urgent action needed to improve outcomes for lung cancer patients, says expert

Urgent action is needed to improve outcomes for lung cancer patients, a leading lung cancer expert will explain in a public lecture at the University of Leicester.

5 Oct 2012

New gene test can detect pre-cancerous cells in patients with mouth lesions

Researchers from Queen Mary, University of London have developed a new gene test that can detect pre-cancerous cells in patients with benign-looking mouth lesions. The test could potentially allow at-risk patients to receive earlier treatment, significantly improving their chance of survival.

5 Oct 2012

Risk of Lyme disease to increase this fall: CAPC

Leading parasitologists with the nonprofit Companion Animal Parasite Council say the risk of Lyme disease will increase this fall.

5 Oct 2012

FDA licenses Quotient’s ALBAsera products

Quotient Biodiagnostics, Inc., a supplier of innovative and high-quality transfusion diagnostic products to hospitals, blood banks and other healthcare institutions, is pleased to announce that its range of ALBAsera Rare Antisera products have been licensed for sale by the U.S. Food and Drug Administration (FDA).

5 Oct 2012

Five ACS members receive 2012 Surgical Humanitarian and Volunteerism Awards

Earlier this evening, five members of the American College of Surgeons (ACS) were named recipients of the 2012 Surgical Humanitarian and Volunteerism Award of the College and Pfizer in recognition for their selfless efforts as volunteer surgeons who provide care to medically underserved patients, domestically and abroad.

5 Oct 2012

Diagnostic News and Research

MDD with subthreshold hypomania ‘should be merged with bipolar II’

FDA clears Surefire's Angiographic Catheter line

Salivary-biomarker approach can identify individuals at future risk of PTSD, depression

CT technique could improve COPD classification

Isolated fetal echogenic bowel ‘may be benign’

PENTAX Medical to release new EPK-i7000 video processor and i10 series endoscopes

Eddy Scurlock Stroke Center receives DNV's Comprehensive Stroke Center certification

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

NovaSom launches full-service testing program for pre-operative diagnosis of OSA

Standard red blood cell transfusion as good as fresh RBCs for premature infants

St. Jude Medical launches 3-D navigation system that reduces need for live fluoroscopy

Rainbow, Amarantus report joint venture agreement for NuroPro Parkinson's diagnostic platform

Patient navigation services can reduce dangerous delays in identification of breast cancer

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

GW professor to develop blood test for early detection of breast cancer

Urgent action needed to improve outcomes for lung cancer patients, says expert

New gene test can detect pre-cancerous cells in patients with mouth lesions

Risk of Lyme disease to increase this fall: CAPC

FDA licenses Quotient’s ALBAsera products

Five ACS members receive 2012 Surgical Humanitarian and Volunteerism Awards

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News